Dmitriy Zamarin on Dealing With Side Effects from T-VEC Treatment in Melanoma

Video

Dmitriy Zamarin, MD, PhD, assistant attending physician at Memorial Sloan Kettering Cancer Center, discusses side effects that nurses should look our for when treating patients with the T-VEC virus.

Dmitriy Zamarin, MD, PhD, assistant attending physician at Memorial Sloan Kettering Cancer Center, discusses side effects that nurses should look our for when treating patients with the T-VEC virus.

T-VEC, which is approved for the treatment of melanoma, is an oncolytic virus that Zamarin says typically has little side effects for patients. The most common effects are inflammation at the injection site or a fever, both of which are signs that the immune system is working. However, it is possible to get a bacterial infection at the injection site, which would be something that the patient would need to seek care from the nurse or doctor for.

Recent Videos
Ann H. Partridge, MD, MPH, in an interview with Oncology Nursing News at 2024 ESMO Congress.
Elizabeth Burton in an interview with Oncology Nursing News
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.